LEO Pharma Selects Aris Global’s Register(TM) for Regulatory Affairs Management

CHICAGO & BALLERUP, Denmark--(BUSINESS WIRE)--DIA ANNUAL CONFERENCE—Aris Global, a leading provider of software solutions for the life sciences industry and LEO Pharma, a global, independent, research-based pharmaceutical company, today announced that LEO Pharma will deploy Aris Global’s Register as its integrated Regulatory Affairs management system. Using Register, LEO Pharma expects that authorized users will be able to track and monitor the drug product, country- and company-specific registration data at the global and/or at the local level with much greater ease and confidence.

Back to news